{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:54:37Z","timestamp":1793321677135,"version":"4.5.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Medications for addiction treatment (MAT) are inconsistently offered in HIV clinics.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the impact of implementation facilitation (hereafter referred to as \u201cfacilitation\u201d), a multicomponent implementation strategy, on increasing provision of MAT for opioid use disorder (MOUD), alcohol use disorder (MAUD), and tobacco use disorder (MTUD).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>Conducted from July 26, 2016, through July 25, 2020, the Working with HIV Clinics to adopt Addiction Treatment using Implementation Facilitation (WHAT-IF?) study used an unblinded, stepped wedge design to sequentially assign each of 4 HIV clinics in the northeastern US to cross over from control (ie, baseline practices) to facilitation (ie, intervention) and then evaluation and maintenance periods every 6 months. Participants were adult patients with opioid, alcohol, or tobacco use disorder. Data analysis was performed from August 2020 to September 2022.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Multicomponent facilitation.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Outcomes, assessed using electronic health record data, were provision of MAT among patients with opioid, alcohol, or tobacco use disorder during the evaluation (primary outcome) and maintenance periods compared with the control period.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 3647 patients, the mean (SD) age was 49 (12) years, 1814 (50%) were Black, 781 (22%) were Hispanic, and 1407 (39%) were female; 121 (3%) had opioid use disorder, 126 (3%) had alcohol use disorder, and 420 (12%) had tobacco use disorder. Compared with the control period, there was no increase in provision of MOUD with facilitation during the evaluation period (243 patients [27%; 95% CI, 22%-32%] vs 135 patients [28%; 95% CI, 22%-35%]; P<\/jats:italic>\u2009=\u2009.59) or maintenance period (198 patients [29%; 95% CI, 22%-36%]; P<\/jats:italic>\u2009=\u2009.48). The change in provision of MAUD from the control period to the evaluation period was not statistically significant (251 patients [8%; 95% CI, 5%-12%] vs 112 patients [13%; 95% CI, 8%-21%]; P<\/jats:italic>\u2009=\u2009.11); however, the difference increased and became significant during the maintenance period (180 patients [17%; 95% CI, 12%-24%]; P<\/jats:italic>\u2009=\u2009.009). There were significant increases in provision of MTUD with facilitation during both the evaluation (810 patients [33%; 95% CI, 30%-36%] vs 471 patients [40%; 95% CI, 36%-45%]; P<\/jats:italic>\u2009=\u2009.005) and maintenance (643 patients [38%; 95% CI, 34%-41%]; P<\/jats:italic>\u2009=\u2009.047) periods.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this randomized clinical trial, facilitation led to increased provision of MTUD, delayed improvements in MAUD, and no improvements in MOUD in HIV clinics. Enhanced strategies, potentially including clinic and patient incentives, especially for MOUD, may be needed to further increase provision of MAT in HIV clinics.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT02907944<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.36904","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T15:35:13Z","timestamp":1666020913000},"page":"e2236904","source":"Crossref","is-referenced-by-count":13,"title":["Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics"],"prefix":"10.1001","volume":"5","author":[{"given":"E. Jennifer","family":"Edelman","sequence":"first","affiliation":[{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geliang","family":"Gan","sequence":"additional","affiliation":[{"name":"Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[{"name":"Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Esserman","sequence":"additional","affiliation":[{"name":"Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, Connecticut"},{"name":"Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Porter","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Becker","sequence":"additional","affiliation":[{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"VA Connecticut Healthcare System, West Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Brown University, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah H.","family":"Cornman","sequence":"additional","affiliation":[{"name":"Institute for Collaboration on Health, Intervention, and Policy (InCHIP), University of Connecticut, Storrs"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Helfrich","sequence":"additional","affiliation":[{"name":"University of Washington and VA Puget Sound, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Yale Center for Analytic Sciences, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E.","family":"Yager","sequence":"additional","affiliation":[{"name":"SUNY Downstate, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Morford","sequence":"additional","affiliation":[{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas B.","family":"Muvvala","sequence":"additional","affiliation":[{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[{"name":"Program in Addiction Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, Connecticut"},{"name":"Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"zoi221049r2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jsat.2019.11.002","article-title":"Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.","volume":"109","author":"Oldfield","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"zoi221049r3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pcad.2020.01.003","article-title":"Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.","volume":"63","author":"Shahrir","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"zoi221049r4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugalcdep.2016.01.015","article-title":"HIV primary care providers: screening, knowledge, attitudes and behaviors related to alcohol interventions.","volume":"161","author":"Chander","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi221049r5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/tbm\/ibac022","article-title":"Practices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics: a multisite cross-sectional survey.","volume":"12","author":"Bold","year":"2022","journal-title":"Transl Behav Med"},{"issue":"1","key":"zoi221049r7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1370\/afm.1312","article-title":"Systematic review and meta-analysis of practice facilitation within primary care settings.","volume":"10","author":"Baskerville","year":"2012","journal-title":"Ann Fam Med"},{"issue":"11","key":"zoi221049r8","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1007\/s11606-018-4581-9","article-title":"Impact of practice facilitation in primary care on chronic disease care processes and outcomes: a systematic review.","volume":"33","author":"Wang","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi221049r9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","article-title":"Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).","volume":"14","author":"D\u2019Onofrio","year":"2019","journal-title":"Implement Sci"},{"issue":"1","key":"zoi221049r10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13722-019-0134-8","article-title":"Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.","volume":"14","author":"Williams","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"zoi221049r11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1513\/AnnalsATS.201410-466BC","article-title":"Academic detailing interventions improve tobacco use treatment among physicians working in underserved communities.","volume":"12","author":"Leone","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"zoi221049r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2020.106156","article-title":"Working with HIV clinics to adopt addiction treatment using implementation facilitation (WHAT-IF?): rationale and design for a hybrid type 3 effectiveness-implementation study.","volume":"98","author":"Edelman","year":"2020","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"zoi221049r14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/QAI.0000000000002666","article-title":"Readiness to provide medications for opioid, alcohol and tobacco use disorder in HIV clinics: a multi-site mixed-methods formative evaluation.","volume":"87","author":"Edelman","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"zoi221049r15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact.","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"key":"zoi221049r16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13063-015-0839-2","article-title":"Stepped wedge randomised controlled trials: systematic review of studies published between 2010 and 2014.","volume":"16","author":"Beard","year":"2015","journal-title":"Trials"},{"issue":"11","key":"zoi221049r17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi221049r18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s43058-021-00165-2","article-title":"The development and evaluation of an HIV implementation science network in New England: lessons learned.","volume":"2","author":"van den Berg","year":"2021","journal-title":"Implement Sci Commun"},{"key":"zoi221049r19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1748-5908-4-38","article-title":"Organizational readiness to change assessment (ORCA): development of an instrument based on the Promoting Action on Research in Health Services (PARIHS) framework.","volume":"4","author":"Helfrich","year":"2009","journal-title":"Implement Sci"},{"issue":"5","key":"zoi221049r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department\u2013initiated buprenorphine.","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi221049r21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jsat.2008.08.004","article-title":"Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review.","volume":"36","author":"Garner","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi221049r22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jsat.2006.03.013","article-title":"Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors.","volume":"30","author":"Knudsen","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"zoi221049r23","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s11606-014-3027-2","article-title":"Outcomes of a partnered facilitation strategy to implement primary care-mental health.","volume":"29","author":"Kirchner","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"7","key":"zoi221049r24","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jclinepi.2013.01.009","article-title":"Stepped wedge designs could reduce the required sample size in cluster randomized trials.","volume":"66","author":"Woertman","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi221049r26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00952990.2012.715703","article-title":"Physician detection of unhealthy substance use on inpatient teaching and hospitalist medical services.","volume":"39","author":"Holt","year":"2013","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"zoi221049r27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1037\/0893-164X.18.3.284","article-title":"Imagery-induced tobacco craving: duration and lack of assessment reactivity bias.","volume":"18","author":"Heishman","year":"2004","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"zoi221049r28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13063-018-3116-3","article-title":"Introducing the new CONSORT extension for stepped-wedge cluster randomised trials.","volume":"20","author":"Hemming","year":"2019","journal-title":"Trials"},{"key":"zoi221049r1","unstructured":"Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. February 2021. Accessed September 12, 2022. https:\/\/health.gov\/healthypeople\/tools-action\/browse-evidence-based-resources\/guidelines-use-antiretroviral-agents-adults-and-adolescents-living-hiv"},{"key":"zoi221049r6","unstructured":"Ritchie? MJ, Dollar? KM, Miller? CJ, . Using implementation facilitation to improve care in the Veterans Health Administration (version 2). 2017. Accessed September 12, 2022. https:\/\/www.queri.research.va.gov\/tools\/Facilitation-Manual.pdf"},{"key":"zoi221049r12","unstructured":"NIH Research Portfolio Online Reporting Tools (RePORT). Implementation to motivate physician response to opioid dependence in HIV setting. Accessed September 7, 2021. https:\/\/reporter.nih.gov\/search\/Z9RxTlyRv0yPQ__0ft3Kkg\/project-details\/9656986#publications"},{"key":"zoi221049r25","unstructured":"HRSA. HIV\/AIDS Bureau performance measures. November 2, 2019. Accessed September 12, 2022. https:\/\/hab.hrsa.gov\/sites\/default\/files\/hab\/clinical-quality-management\/adolescentadultmeasures.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797396\/edelman_2022_oi_221049_1665074973.5697.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T15:35:17Z","timestamp":1666020917000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797396"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36904","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}